Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
08 2020
Historique:
received: 11 03 2020
revised: 28 05 2020
accepted: 29 05 2020
entrez: 24 6 2020
pubmed: 24 6 2020
medline: 15 7 2021
Statut: epublish

Résumé

Genome-wide association studies have implicated the TAM receptor tyrosine kinase (RTK) Mer in liver disease, yet our understanding of the role that Mer and its related RTKs Tyro3 and Axl play in liver homeostasis and the response to acute injury is limited. We find that Mer and Axl are most prominently expressed in hepatic Kupffer and endothelial cells and that as mice lacking these RTKs age, they develop profound liver disease characterized by apoptotic cell accumulation and immune activation. We further find that Mer is critical to the phagocytosis of apoptotic hepatocytes generated in settings of acute hepatic injury, and that Mer and Axl act in concert to inhibit cytokine production in these settings. In contrast, we find that Axl is uniquely important in mitigating liver damage during acetaminophen intoxication. Although Mer and Axl are protective in acute injury models, we find that Axl exacerbates fibrosis in a model of chronic injury. These divergent effects have important implications for the design and implementation of TAM-directed therapeutics that might target these RTKs in the liver.

Identifiants

pubmed: 32571802
pii: 3/8/e202000694
doi: 10.26508/lsa.202000694
pmc: PMC7335405
pii:
doi:

Substances chimiques

Proto-Oncogene Proteins 0
Mertk protein, mouse EC 2.7.10.1
Receptor Protein-Tyrosine Kinases EC 2.7.10.1
c-Mer Tyrosine Kinase EC 2.7.10.1
Axl Receptor Tyrosine Kinase 0
AXL receptor tyrosine kinase, mouse 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P30 CA014195
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI101400
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS085296
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG060748
Pays : United States

Informations de copyright

© 2020 Zagórska et al.

Références

Science. 2001 Jul 13;293(5528):306-11
pubmed: 11452127
Immunity. 2013 Jan 24;38(1):79-91
pubmed: 23273845
Cell. 2013 Dec 19;155(7):1596-609
pubmed: 24360280
Cold Spring Harb Perspect Biol. 2013 Nov 01;5(11):a009076
pubmed: 24186067
J Exp Med. 2006 Aug 7;203(8):1891-901
pubmed: 16831897
Elife. 2016 Jun 28;5:
pubmed: 27350258
Free Radic Biol Med. 2013 Dec;65:1246-1256
pubmed: 24064382
Curr Opin Immunol. 2015 Oct;36:61-6
pubmed: 26186123
Cell Death Dis. 2015 Feb 19;6:e1646
pubmed: 25695599
J Exp Med. 1987 Mar 1;165(3):657-63
pubmed: 3819645
World J Gastroenterol. 2014 Mar 14;20(10):2564-77
pubmed: 24627592
Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):503
pubmed: 23877532
Elife. 2014 Sep 29;3:
pubmed: 25265470
Biochem Biophys Res Commun. 2013 Jun 21;436(1):96-103
pubmed: 23707809
Nature. 2001 May 10;411(6834):207-11
pubmed: 11346799
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):231-42
pubmed: 25782093
Clin Mol Hepatol. 2012 Dec;18(4):337-46
pubmed: 23323248
Nat Rev Immunol. 2008 May;8(5):327-36
pubmed: 18421305
Nature. 1999 Aug 26;400(6747):886-91
pubmed: 10476969
Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G899-905
pubmed: 26867565
J Exp Med. 1994 May 1;179(5):1437-44
pubmed: 8163930
Nature. 2016 Apr 14;532(7598):240-244
pubmed: 27049947
Mucosal Immunol. 2015 Sep;8(5):1021-1030
pubmed: 25603826
Cell Mol Gastroenterol Hepatol. 2020;9(3):349-368
pubmed: 31689560
Hepatology. 2010 Oct;52(4):1371-9
pubmed: 20730776
Gut. 2016 Oct;65(10):1754-64
pubmed: 26045137
Int J Mol Sci. 2019 Oct 12;20(20):
pubmed: 31614787
Clin Liver Dis. 2014 Feb;18(1):1-18
pubmed: 24274861
J Clin Med. 2018 Nov 23;7(12):
pubmed: 30477195
J Med Virol. 2016 Feb;88(2):185-95
pubmed: 26211651
Gastroenterology. 2012 Nov;143(5):1244-1252.e12
pubmed: 22841784
Nat Immunol. 2012 Nov;13(11):1118-28
pubmed: 23023392
Crit Rev Toxicol. 2003;33(2):105-36
pubmed: 12708612
Clin Immunol. 2016 Aug;169:58-68
pubmed: 27237127
Semin Liver Dis. 2019 May;39(2):221-234
pubmed: 30849782
J Immunol. 2014 Jul 1;193(1):344-53
pubmed: 24890723
Hepatol Res. 2017 Jul;47(8):826-830
pubmed: 27577861
Nat Rev Immunol. 2019 Sep;19(9):539-549
pubmed: 31019284
Cell Metab. 2020 Feb 4;31(2):406-421.e7
pubmed: 31839486
Nat Immunol. 2014 Oct;15(10):920-8
pubmed: 25194421
J Hepatol. 2017 Jun;66(6):1300-1312
pubmed: 28267621
Clin Liver Dis. 2018 May;22(2):325-346
pubmed: 29605069
Cell. 2007 Dec 14;131(6):1124-36
pubmed: 18083102
J Hepatol. 2017 Apr;66(4):787-797
pubmed: 27965156
Hepatology. 2006 Mar;43(3):435-43
pubmed: 16496318
Nat Rev Gastroenterol Hepatol. 2009 Sep;6(9):542-53
pubmed: 19652652
Hum Mol Genet. 2017 May 1;26(9):1747-1758
pubmed: 28334911
Cell. 2013 Apr 25;153(3):601-13
pubmed: 23622244
Nature. 1993 Aug 26;364(6440):806-9
pubmed: 7689176
Trends Biochem Sci. 2017 Sep;42(9):738-748
pubmed: 28734578
Gastroenterology. 2015 Mar;148(3):603-615.e14
pubmed: 25479139
Nat Med. 1996 Jan;2(1):80-6
pubmed: 8564847
Ann N Y Acad Sci. 2010 Oct;1209:23-9
pubmed: 20958312
J Biol Chem. 2004 Jul 2;279(27):28766-70
pubmed: 15123721
Nat Immunol. 2016 Jun 21;17(7):741
pubmed: 27327993
Nature. 1999 Apr 22;398(6729):723-8
pubmed: 10227296
Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G1043-53
pubmed: 21350191
Oncol Rep. 2016 Aug;36(2):613-25
pubmed: 27278244
Gut. 2015 Oct;64(10):1605-15
pubmed: 25214320
Oncotarget. 2016 Nov 22;7(47):77291-77305
pubmed: 27764792
Gut. 2018 Feb;67(2):333-347
pubmed: 28450389
J Hepatol. 2015 Sep;63(3):670-8
pubmed: 25908269
J Hepatol. 2009 Jul;51(1):139-48
pubmed: 19457567
J Hepatol. 2016 Mar;64(3):682-90
pubmed: 26596542
Oncotarget. 2017 Jul 11;8(28):46234-46248
pubmed: 28526812
Life Sci Alliance. 2019 Dec 10;3(1):
pubmed: 31822557

Auteurs

Anna Zagórska (A)

Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA, USA.

Paqui G Través (PG)

Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA, USA.
Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain.

Lidia Jiménez-García (L)

Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA, USA.

Jenna D Strickland (JD)

Department of Pharmacology & Toxicology, Michigan State University, East Lansing, MI, USA.

Joanne Oh (J)

Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA, USA.

Francisco J Tapia (FJ)

Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA, USA.

Rafael Mayoral (R)

Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.

Patrick Burrola (P)

Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA, USA.

Bryan L Copple (BL)

Department of Pharmacology & Toxicology, Michigan State University, East Lansing, MI, USA.

Greg Lemke (G)

Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA, USA lemke@salk.edu.
Immunobiology and Microbial Pathogenesis Laboratory, The Salk Institute, La Jolla, CA, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH